keyword
MENU ▼
Read by QxMD icon Read
search

Urologic oncology

keyword
https://www.readbyqxmd.com/read/29759257/developing-a-medical-scribe-program-at-an-academic-hospital-the-hennepin-county-medical-center-experience
#1
Marc L Martel, Brian H Imdieke, Kayla M Holm, Sara Poplau, William G Heegaard, Jon L Pryor, Mark Linzer
BACKGROUND: Medical scribes are frequently incorporated into the patient care model to improve provider efficiency and enable providers to refocus their attention to the patient rather than the electronic health record (EHR). The medical scribe program was based on four pillars (objectives): (1) provider satisfaction, (2) standardized documentation, (3) documentation components for risk adjustment, and (4) revenue enhancement. METHODS: The medical scribe program was deployed in nine non-resident-supported clinics (internal medicine, ophthalmology, orthopedics, hematology/oncology, urology), with the medical scribes (who have no clinical duties) supporting both physicians and advanced practice providers (nurse practitioners and physician assistants)...
May 2018: Joint Commission Journal on Quality and Patient Safety
https://www.readbyqxmd.com/read/29757570/incidence-and-treatment-of-malignant-tumors-of-the-genitourinary-tract-in-renal-transplant-recipients
#2
Juan Manuel Ochoa-López, Bernardo Gabilondo-Pliego, Sylvain Collura-Merlier, Jaime O Herrera-Cáceres, Mariano Sotomayor de Zavaleta, Francisco Tomás Rodríguez-Covarrubias, Guillermo Feria-Bernal, Fernando Gabilondo-Navarro, Ricardo Alonso Castillejos-Molina
PURPOSE: To provide data of the incidence and management of common urological malignancies in renal transplant recipients. MATERIALS AND METHODS: We conducted a retrospective analysis of a prospective database from August 1967 to August 2015. A descriptive analysis of the sample was performed. RESULTS: Among 1256 consecutive RTR a total of 88 patients developed malignancies (7%). There were 18 genitourinary tumors in the 16 patients (20.45% of all malignant neoplasms), incidence of 1...
April 30, 2018: International Braz J Urol: Official Journal of the Brazilian Society of Urology
https://www.readbyqxmd.com/read/29753463/de-novo-urologic-malignancies-in-renal-transplant-recipients
#3
H Antunes, E Tavares-da-Silva, R Oliveira, J Carvalho, B Parada, C Bastos, A Figueiredo
BACKGROUND: Immunosuppressed organ transplant patients have an elevated risk of malignancies. The aim of this study was to determine the incidence of urologic malignancies in renal transplant recipients, as well as to evaluate their monitoring, treatment, and outcomes. METHODS: We conducted a retrospective single-center study of 2897 renal transplants between January 1987 and December 2016. Recipients presenting with de novo urologic malignancies were evaluated...
March 10, 2018: Transplantation Proceedings
https://www.readbyqxmd.com/read/29742686/a-rare-case-report-of-one-stage-surgical-treatment-for-left-renal-cell-carcinoma-with-level-iv-intravenous-tumor-thrombus-combined-with-severe-coronary-artery-stenosis
#4
Zhenqing Wang, Keqin Zhang, Hui Zhang, Dingqi Sun, Yong Li, Qi Tan, Qiang Fu
RATIONALE: Renal cell carcinoma (RCC) exhibits a natural tendency to extend from the kidney into inferior vena cava (IVC) and growing into the right atrium is a rare complication. We report a 65-year-old patient with an RCC with intravascular extension through renal vein into the IVC and right atrial combined with severe coronary artery disease. This case has not been described in the literature and there is no treatment guideline for it. PATIENT CONCERNS: A 65-year-old patient was admitted to our clinic with complaints of edema of both lower extremities...
May 2018: Medicine (Baltimore)
https://www.readbyqxmd.com/read/29721042/a-real-world-data-study-to-evaluate-treatment-patterns-clinical-characteristics-and-survival-outcomes-for-first-and-second-line-treatment-in-locally-advanced-and-metastatic-urothelial-cancer-patients-in-germany
#5
Günter Niegisch, Holger Gerullis, Shih-Wen Lin, Julie Pavlova, Adam Gondos, Anja Rudolph, Gabriele Haas, Nora Hennies, Mario W Kramer
Background : Worldwide, urothelial carcinoma (UC) is a common cause of morbidity and mortality. In particular, the incidence of bladder cancer varies widely across Europe; Germany has the ninth highest international age-standardized incidence. For advanced UC or metastatic UC (mUC), platinum-based combination chemotherapy is the standard first-line (1L) treatment; however, there is wide heterogeneity of second-line (2L) treatments, ranging from vinflunine in parts of Europe to taxanes and other agents elsewhere in Europe, in the United States and globally...
2018: Journal of Cancer
https://www.readbyqxmd.com/read/29720406/contemporary-prostate-biopsy-reporting-insights-from-a-survey-of-clinicians-use-of-pathology-data
#6
Murali Varma, Krishna Narahari, Malcolm Mason, Jon D Oxley, Daniel M Berney
AIM: To determine how clinicians use data in contemporary prostate biopsy reports. METHODS: A survey was circulated to members of the British Association of Urological Surgeons and the British Uro-oncology Group. RESULTS: Responses were received from 114 respondents (88 urologists, 26 oncologists). Ninety-seven (94%) use the number of positive cores from each side and 43 (42%) use the % number of positive cores. When determining the number and percentage of positive cores, 72 (71%) would not differentiate between targeted and non-targeted samples...
May 2, 2018: Journal of Clinical Pathology
https://www.readbyqxmd.com/read/29719323/saudi-oncology-society-and-saudi-urology-association-combined-clinical-management-guidelines-for-prostate-cancer-2017
#7
REVIEW
Ali Aljubran, Ashraf Abusamra, Sultan Alkhateeb, Mohammed Alotaibi, Danny Rabah, Shouki Bazarbashi, Hussain Alkushi, Mubarak Al-Mansour, Hulayel Alharbi, Amin Eltijani, Abdullah Alghamdi, Abdullah Alsharm, Imran Ahmad, Esam Murshid
This is an update to the previously published Saudi guidelines for the evaluation and medical and surgical management of patients diagnosed with prostate cancer. Prostate cancer is categorized according to the stage of the disease using the tumor node metastasis staging system 7th edition. The guidelines are presented with supporting evidence levels based on a comprehensive literature review, several internationally recognized guidelines, and the collective expertise of the guidelines committee members (authors) who were selected by the Saudi Oncology Society and Saudi Urological Association...
April 2018: Urology Annals
https://www.readbyqxmd.com/read/29719322/saudi-oncology-society-and-saudi-urology-association-combined-clinical-management-guidelines-for-urothelial-cell-carcinoma-of-the-urinary-bladder-2017
#8
REVIEW
Hulayel Alharbi, Sultan Alkhateeb, Esam Murshid, Mohammed Alotaibi, Ashraf Abusamra, Danny Rabah, Mubarak Almansour, Abdullah Alghamdi, Ali Aljubran, Amin Eltigani, Hussein Alkushi, Imran Ahmed, Abdullah Alsharm, Shouki Bazarbashi
This is an update to the previously published Saudi guidelines for the evaluation and medical/surgical management of patients diagnosed with urothelial cell carcinoma of the urinary bladder. It is categorized according to the stage of the disease using the tumor node metastasis staging system, 7th edition. The guidelines are presented with their accompanying supporting evidence level, which is based on comprehensive literature review, several internationally recognized guidelines, and the collective expertise of the guidelines committee members (authors) who were selected by the Saudi Oncology Society and Saudi Urological Association...
April 2018: Urology Annals
https://www.readbyqxmd.com/read/29719321/saudi-oncology-society-and-saudi-urology-association-combined-clinical-management-guidelines-for-renal-cell-carcinoma-2017
#9
REVIEW
Abdullah Alsharm, Shouki Bazarbashi, Abdullah Alghamdi, Sultan Alkhateeb, Ali Aljubran, Ashraf Abusamra, Hulayel Alharbi, Mohammed Alotaibi, Mubarak Almansour, Hussein Alkushi, Imran Ahmed, Esam Murshid, Amin Eltijani, Danny Rabah
In this report, we update the previously published Saudi guidelines for the evaluation and medical and surgical management of renal cell carcinoma. It is categorized according to the stage of the disease using the tumor node metastasis staging system 7th edition. The recommendations are presented with supporting evidence level.
April 2018: Urology Annals
https://www.readbyqxmd.com/read/29704209/neurologic-manifestations-of-elderly-patients-with-cancer
#10
Bernardo Cacho-Díaz, Nydia A Lorenzana-Mendoza, Gervith Reyes-Soto, José A Ávila-Funes, Ana P Navarrete-Reyes
BACKGROUND: The incidence of cancer is an age-related phenomenon; therefore, the interest on clinical manifestations, diagnostic approach and treatment strategies for older patients diagnosed with cancer has increased lately. Neurologic symptoms are one of the main reasons for consultation and a common cause of decreased quality of life among cancer patients. AIMS: To identify the neurologic manifestations of patients ≥ 65 years of age diagnosed with cancer and compare them to those presented by a younger population...
April 27, 2018: Aging Clinical and Experimental Research
https://www.readbyqxmd.com/read/29701416/co-existence-of-abdominal-aortic-aneurysm-with-urologic-neoplasm-which-should-be-treated-first-in-the-endovascular-era
#11
José Oliveiar-Pinto, Nilo Mosquera, José Vidoedo, Sérgio Moreira-Sampaio, José Teixeira
INTRODUCTION: Prevalence of Abdominal Aortic Aneurysm (AAA) with concomitant malignancy rounds 3-13%. Considering only urological neoplasms the prevalence is around 3.6%. Survival at 5 years of bladder carcinoma without extravesical invasion (stage II) rounds 63%. Endovascular Aneurysm Repair (EVAR), due to its minimally invasive profile, is an option for treatment of AAA prior to urological surgery as it does not require laparotomy not conditioning the delay of oncologic surgery. METHODS: Male, 62 years old...
July 2017: Revista Portuguesa de Cirurgia Cardio-torácica e Vascular
https://www.readbyqxmd.com/read/29696234/reduce-bladder-cancer-recurrence-in-patients-treated-for-upper-urinary-tract-urothelial-carcinoma-the-rebacare-trial
#12
T van Doeveren, P J van Leeuwen, K K H Aben, M van der Aa, M Barendrecht, E R Boevé, E B Cornel, A G van der Heijden, K Hendricksen, W Hirdes, A Kooistra, B Kroon, A M Leliveld, R P Meijer, H van Melick, B Merks, T M de Reijke, P de Vries, L F A Wymenga, B Wijsman, J L Boormans
Background: Following radical nephro-ureterectomy for urothelial carcinoma of the upper urinary tract (UUT), the reported bladder recurrence rate of urothelial carcinoma is 22-47%. A single intravesical instillation of chemotherapy within 10 days following nephro-ureterectomy has the potential to decrease the risk of a bladder recurrence significantly. Despite recommendation by the European Association of Urology guideline to administer a single instillation postoperatively, the compliance rate is low because the risk of extravasation of chemotherapy...
March 2018: Contemporary Clinical Trials Communications
https://www.readbyqxmd.com/read/29666835/aptamers-and-apple-pies-a-mini-review-of-psma-aptamers-and-lessons-from-donald-s-coffey
#13
REVIEW
Shawn E Lupold
This mini-review article is part of a special issue dedicated to Donald S. Coffey, a pioneer translational research scientist, exemplary mentor, and leader in urologic and urologic oncology research. This article first briefly reflects on life and scientific lessons from Don Coffey. It then reviews the development of two prostate cancer targeting RNA aptamers, xPSM-A9 and xPSM-A10, through in vitro selection for aptamers that bind to the extracellular domain of the Prostate Specific Membrane Antigen (PSMA)...
2018: American Journal of Clinical and Experimental Urology
https://www.readbyqxmd.com/read/29662542/meta-analysis-of-studies-comparing-oncologic-outcomes-of-radical-prostatectomy-and-brachytherapy-for-localized-prostate-cancer
#14
Gabriele Cozzi, Gennaro Musi, Roberto Bianchi, Danilo Bottero, Antonio Brescia, Antonio Cioffi, Giovanni Cordima, Maurizio Delor, Ettore Di Trapani, Matteo Ferro, Deliu Victor Matei, Andrea Russo, Francesco Alessandro Mistretta, Ottavio De Cobelli
Background: The aim of this study was to compare oncologic outcomes of radical prostatectomy (RP) with brachytherapy (BT). Methods: A literature review was conducted according to the 'Preferred reporting items for systematic reviews and meta-analyses' (PRISMA) statement. We included studies reporting comparative oncologic outcomes of RP versus BT for localized prostate cancer (PCa). From each comparative study, we extracted the study design, the number and features of the included patients, and the oncologic outcomes expressed as all-cause mortality (ACM), PCa-specific mortality (PCSM) or, when the former were unavailable, as biochemical recurrence (BCR)...
November 2017: Therapeutic Advances in Urology
https://www.readbyqxmd.com/read/29661588/impact-of-metabolic-diseases-drugs-and-dietary-factors-on-prostate-cancer-risk-recurrence-and-survival-a-systematic-review-by-the-european-association-of-urology-section-of-oncological-urology
#15
REVIEW
Riccardo Campi, Sabine D Brookman-May, Jose Daniel Subiela Henríquez, Bülent Akdoğan, Maurizio Brausi, Tobias Klatte, Johan F Langenhuijsen, Estefania Linares-Espinos, Martin Marszalek, Morgan Roupret, Christian G Stief, Alessandro Volpe, Andrea Minervini, Oscar Rodriguez-Faba
CONTEXT: To date, established risk factors for prostate cancer (PCa) are limited to age, race, family history, and certain genetic polymorphisms. Despite great research efforts, available evidence on potentially modifiable risk factors is conflicting. Moreover, most studies on PCa risk factors did not consider the impact of prostate-specific antigen (PSA) testing on PCa diagnosis. OBJECTIVE: To provide a detailed overview of the latest evidence on the role of metabolic diseases, drugs, and dietary factors for risk of PCa incidence, recurrence, and survival in men exposed to PSA testing...
April 13, 2018: European Urology Focus
https://www.readbyqxmd.com/read/29658681/laparoscopic-radical-prostatectomy-in-2018-20-years-of-worldwide-experiences-experimentations-researches-and-refinements
#16
Aldo Brassetti, Renaud Bollens
INTRODUCTION: After the first feasibility report in 1997, a growing interest has risen in the urologic community for laparoscopic radical prostatectomy (LRP) and several authors have contributed to the evolution of the technique. We attempt a review of the available evidences and provide a broad framework of different technical refinements considering their impact on pentafecta. EVIDENCE ACQUISITION: The PubMed/Medline database was searched. Duplicates and "Expert opinion" papers were removed...
April 13, 2018: Minerva Chirurgica
https://www.readbyqxmd.com/read/29645348/retzius-sparing-robot-assisted-radical-prostatectomy-using-revo-i-robotic-surgical-system-surgical-technique-and-results-of-the-first-human-trial
#17
Ki Don Chang, Ali Abdel Raheem, Young Deuk Choi, Byung Ha Chung, Koon Ho Rha
PURPOSE: Recently, Revo-i® robotic surgical system has been proved to be safe in the preclinical animal studies. Our aim was to evaluate the safety and proficiency of Revo-i® robotic platform in the treatment of prostate cancer (PCa). PATIENTS AND METHODS: A prospective study was carried out on 17 male patients with clinically localized PCa from August 17, 2016, to Feb 23, 2017 at our urology department using Revo-i® . Patients underwent Retzius-sparing robot-assisted radical prostatectomy (RP-RARP)...
April 12, 2018: BJU International
https://www.readbyqxmd.com/read/29629862/identifying-the-use-and-barriers-to-the-adoption-of-renal-tumour-biopsy-in-the-management-of-small-renal-masses
#18
Patrick O Richard, Lisa Martin, Luke T Lavallée, Philippe D Violette, Maria Komisarenko, Andrew J Evans, Kunal Jain, Michael A S Jewett, Antonio Finelli
INTRODUCTION: Renal tumour biopsies (RTBs) can provide the histology of small renal masses (SRMs) prior to treatment decision making. However, many urologists are reluctant to use RTB as a standard of care. This study characterizes the current use of RTB in the management of SRMs and identifies barriers to a more widespread adoption. METHODS: A web-based survey was sent to members of the Canadian and Quebec Urological Associations who had registered email address (n=767) in June 2016...
April 6, 2018: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/29610962/are-clinical-guidelines-designed-according-to-guidelines-cross-sectional-assessment-of-quality-and-transparency-of-clinical-guidelines-in-urology
#19
Roderick C N van den Bergh, Piet Ost, Christian Surcel, Massimo Valerio, Jurgen J Fütterer, Giorgio Gandaglia, Prasanna Sooriakumaran, Derya Tilki, Igor Tsaur, Guillaume Ploussard
PURPOSE: Guidelines and recommendations become increasingly important in clinical urologic practice. This study aims to inform clinicians using guidelines on how to evaluate the quality of the methodology and transparency of these documents. METHODS: The guidelines on management of castration-resistant prostate cancer of the American Urology Association, European Association of Urology, National Comprehensive Cancer Network, National Institute for Health and Care Excellence, European Society of Medical Oncology were reviewed using the AGREE-II tool (Appraisal of Guidelines for Research and Evaluation)...
April 2, 2018: World Journal of Urology
https://www.readbyqxmd.com/read/29603921/improving-patient-journey-and-quality-of-care-summary-from-the-2nd-bladder-cancer-canada-canadian-urological-association-canadian-urologic-oncology-group-bcc-cua-cuog-bladder-cancer-quality-of-care-consensus-meeting
#20
Wassim Kassouf, Armen Aprikian, Fred Saad, Rodney H Breau, Girish Kulkarni, David M Guttman, Ken Bagshaw, Jonathan Izawa, Libni Eapen, Adrian Fairey, Alan So, Scott North, Ricardo Rendon, Srikala S Sridhar, Fadi Brimo, Peter Chung, Darrel Drachenberg, Yves Fradet, Niels Jacobsen, Chris Morash, Bobby Shayegan, Geoffrey Gotto, Alex Zlotta, Neil Fleshner, D Robert Siemens, Peter C Black
No abstract text is available yet for this article.
March 19, 2018: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
keyword
keyword
51391
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"